Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 3
2012 3
2013 6
2014 10
2015 6
2016 10
2017 3
2018 6
2019 6
2020 5
2021 7
2022 5
2023 3
2024 3
2025 9
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Multi-targeting RNAi approaches for cancer treatment.
Chareddy YS, Pecot CV. Chareddy YS, et al. Among authors: pecot cv. Expert Opin Ther Targets. 2026 Jan;30(1):9-12. doi: 10.1080/14728222.2025.2608025. Epub 2025 Dec 26. Expert Opin Ther Targets. 2026. PMID: 41432708 No abstract available.
Diverse roles of quaking in endothelial cell biology.
Edatt L, Li D, Dudley AC, Pecot CV. Edatt L, et al. Among authors: pecot cv. Angiogenesis. 2025 Nov 12;29(1):4. doi: 10.1007/s10456-025-10020-w. Angiogenesis. 2025. PMID: 41222726 Free PMC article. Review.
Feasibility, Acceptability, and Utility of Remote Patient-Reported Outcomes Monitoring in Patients With Lung Cancer: A Moovcare© Study.
Stover AM, Deal AM, Medley CJ, Weiner AA, Novak L, Gentry AL, Hoch C, Weiss J, Pecot CV, Lee CB, O'Leary MC, Shrestha S, Chen H, Patel SA, Mody GN. Stover AM, et al. Among authors: pecot cv. Clin Lung Cancer. 2025 Dec;26(8):e660-e669.e1. doi: 10.1016/j.cllc.2025.07.016. Epub 2025 Aug 5. Clin Lung Cancer. 2025. PMID: 40850860 Clinical Trial.
Inverted chimeric RNAi molecules synergistically cotarget MYC and KRAS in KRAS-driven cancers.
Chareddy YS, Huggins HP, Sahoo SS, Stanland LJ, Gutierrez-Ford C, Whately KM, Edatt L, Azam SH, Fleming MC, Im J, Porrello A, Simmons I, Perry JL, Bowers AA, Egli M, Pecot CV. Chareddy YS, et al. Among authors: pecot cv. J Clin Invest. 2025 Jul 22;135(19):e187204. doi: 10.1172/JCI187204. eCollection 2025 Oct 1. J Clin Invest. 2025. PMID: 40762837 Free PMC article.
A first-in-class EGFR-directed KRAS G12V selective inhibitor.
Stanland LJ, Huggins HP, Sahoo SS, Porrello A, Chareddy Y, Azam SH, Perry JL, Pallan PS, Whately K, Edatt L, Green WD, Fleming MC, Im J, Gutierrez-Ford C, Simmons I, Dawoud A, Zhou KI, Jayaprakash V, Sellers RS, Cruz G, Wielgus A, Milner J, Egli M, Bowers AA, Pecot CV. Stanland LJ, et al. Among authors: pecot cv. Cancer Cell. 2025 Oct 13;43(10):1815-1832.e10. doi: 10.1016/j.ccell.2025.05.016. Epub 2025 Jun 19. Cancer Cell. 2025. PMID: 40541192 Free article.
Tumor suppressors in Sox2-mediated lung cancers promote distinct cell-intrinsic and immunologic remodeling.
Sengottuvel N, Whately KM, Modliszewski JL, Sellers RS, Green WD, Gong W, Woods AT, Livingston EW, Fagan-Solis KD, Cannon G, Edatt L, Yuan H, Chack AC, Sanchez Y, Zhou K, Dawoud A, Green JM, Godfrey V, Milner JJ, Gupta GP, Pecot CV. Sengottuvel N, et al. Among authors: pecot cv. JCI Insight. 2025 May 6;10(12):e171364. doi: 10.1172/jci.insight.171364. eCollection 2025 Jun 23. JCI Insight. 2025. PMID: 40327401 Free PMC article.
85 results